U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
100381100381Telemonitoring During Phase 2-3 Cardiac RehabilitationCompletedNo Results AvailableIschemic Heart DiseaseDevice: physical activity monitorshttps://ClinicalTrials.gov/show/NCT01252030
100382100382Nilotinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell TransplantationRecruitingNo Results AvailablePatients Who Have Received Allo-HSCTDrug: nilotinibhttps://ClinicalTrials.gov/show/NCT01252017
100383100383French Observatory Syndromes Tako-TsuboCompletedNo Results AvailableMyocardial Necrosis|Tako Tsubo Syndromeshttps://ClinicalTrials.gov/show/NCT01252004
100384100384Cholesterol Lowering Treatment With Psyllium Husks and Isolated Soy Protein in HypercholesterolemiaCompletedNo Results AvailableHypercholesterolemiaDrug: Psyllium husks|Dietary Supplement: Isolated soy protein|Dietary Supplement: Isolated whey protein|Other: Microcrystalline cellulosehttps://ClinicalTrials.gov/show/NCT01251991
100385100385Ranibizumab as Adjuvant Therapy for the Treatment of Choroidal Melanoma (Cohort 2)CompletedNo Results AvailableChoroidal MelanomaDrug: Ranibizumab 2 mg|Drug: 0.5 mg Ranibizumabhttps://ClinicalTrials.gov/show/NCT01251978
100386100386Phase l/II Study of Ruxolitinib for Acute LeukemiaActive, not recruitingNo Results AvailableLeukemiaDrug: Ruxolitinibhttps://ClinicalTrials.gov/show/NCT01251965
100387100387Dose Escalation Trial of Denileukin Diftitox (Ontak) Post Autologous TransplantationTerminatedHas ResultsMultiple MyelomaDrug: Denileukin Diftitox (Ontak)https://ClinicalTrials.gov/show/NCT01251952
100388100388Changes in Renal and Splanchnic Oxygenation During Ibuprofen Treatment for Patent Ductus ArteriousCompletedNo Results AvailableDuctus Arteriosus, PatentDevice: Near-infrared spectroscopy (NIRS)https://ClinicalTrials.gov/show/NCT01251939
100389100389EZN-2208 (Pegylated SN-38) in Combination With Bevacizumab in Refractory Solid TumorsCompletedNo Results AvailableNeoplasmsDrug: EZN-2208|Drug: Bevacizumabhttps://ClinicalTrials.gov/show/NCT01251926
100390100390A Pilot Study of Inpatient Hospice With Procurement of Brain Tumor Tissue on Expiration for Research PurposesTerminatedNo Results AvailableEpendymomas|Gliomas|PNET|Pineal Tumors|PCNSL (Primary CNS Lymphoma)https://ClinicalTrials.gov/show/NCT01251913
100391100391BRCA Mutations in LatinasRecruitingNo Results AvailableBreast Neoplasmshttps://ClinicalTrials.gov/show/NCT01251900
100392100392Dietary Essential Fatty Acid Regulation of Omega-3 HUFA Metabolism; Satiety and Body CompositionRecruitingNo Results AvailableWeight Gain|Healthy Subjects|Obesity|WomenDietary Supplement: Linoleic Acid|Dietary Supplement: Docosahexaenoic Acid|Dietary Supplement: Eicosapentaenoic Acidhttps://ClinicalTrials.gov/show/NCT01251887
100393100393Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast CancerActive, not recruitingNo Results AvailableBRCA1 Mutation Carrier|BRCA2 Mutation Carrier|Estrogen Receptor Negative|Estrogen Receptor Positive|HER2/Neu Negative|Male Breast Carcinoma|Progesterone Receptor Negative|Progesterone Receptor Positive|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|StaDrug: Carboplatin|Other: Fluorothymidine F-18|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Procedure: Positron Emission Tomography|Drug: Veliparibhttps://ClinicalTrials.gov/show/NCT01251874
100394100394Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate CancerActive, not recruitingNo Results AvailableRecurrent Prostate Carcinoma|Stage I Prostate Cancer|Stage IIA Prostate Cancer|Stage IIB Prostate Cancer|Stage III Prostate CancerDrug: Akt Inhibitor MK2206|Drug: Bicalutamide|Other: Clinical Observation|Other: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT01251861
100395100395Drug Interaction Between Ritonavir And SitaxsentanWithdrawnNo Results AvailablePulmonary Arterial HypertensionDrug: Sitaxentan|Drug: Ritonavir|Drug: Sitaxsentan|Drug: Ritonavirhttps://ClinicalTrials.gov/show/NCT01251848
100396100396Effect Of Rifampin On Pharmacokinetics Of SitaxsentanWithdrawnNo Results AvailablePulmonary Arterial HypertensionDrug: Sitaxsentan alone|Drug: Sitaxsentan|Drug: Rifampinhttps://ClinicalTrials.gov/show/NCT01251835
100397100397Comparator Study of PEG 3350 Versus Prucalopride in Females With Chronic ConstipationCompletedNo Results AvailableConstipationDrug: PEG 3350 plus electrolytes|Drug: Prucalopridehttps://ClinicalTrials.gov/show/NCT01251822
100398100398Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic LeukaemiaTerminatedNo Results AvailableAcute Lymphoblastic LeukaemiaDrug: Oncaspar|Drug: PEG-rASNasehttps://ClinicalTrials.gov/show/NCT01251809
100399100399A Study of ARQ 197 in Combination With ErlotinibCompletedNo Results AvailableAdvanced/Recurrent Non-small-cell Lung CancerDrug: ARQ 197 and Erlotinibhttps://ClinicalTrials.gov/show/NCT01251796
100400100400A Prebiotic Agave Derivated Metlin & Metlos in Infant FormulaCompletedNo Results AvailableHealthy Term BabiesDietary Supplement: Infant Formula|Dietary Supplement: Exclusively breast milk|Dietary Supplement: Metlin+metlos+Lactobacillus GG|Dietary Supplement: Metlin + Lactobacillus GG|Dietary Supplement: Metlos + lactobacillus GG|Dietary Supplement: Lactobacillus GGhttps://ClinicalTrials.gov/show/NCT01251783
100401100401Variation in Natremia Using Two Different Maintenance Intravenous Fluids in Postsurgical Hospitalized ChildrenCompletedHas ResultsHyponatremiaDrug: 0.45% NaCl/dextrose 5%|Drug: 0.3% NaCl/dextrose 5%https://ClinicalTrials.gov/show/NCT01251770
100402100402Promoting Adherence to Improve Effectiveness of Cardiovascular Disease TherapiesCompletedNo Results AvailableDiabetes Mellitus|Cardiovascular DiseaseOther: Interactive Voice Recognition (IVR) phone calls|Other: Educational mailings and follow-up for nonadherencehttps://ClinicalTrials.gov/show/NCT01251757
100403100403Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to FoetusCompletedNo Results AvailableInfections, CytomegalovirusProcedure: Blood sample|Procedure: Cord blood sample|Procedure: Saliva swab|Procedure: Urine sampling|Procedure: Vaginal swabhttps://ClinicalTrials.gov/show/NCT01251744
100404100404Single and Multiple Dose Asian Bridging StudyCompletedNo Results AvailableHealthy SubjectsDrug: E5501|Drug: E5501|Drug: E5501|Drug: E5501https://ClinicalTrials.gov/show/NCT01251731
100405100405Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's DiseaseActive, not recruitingNo Results AvailableAlzheimer's DiseaseDrug: donepezil hydrochloridehttps://ClinicalTrials.gov/show/NCT01251718
100406100406Comparation of Different Devices to Measure Corneal ThicknessRecruitingNo Results AvailableCorneal Thicknesshttps://ClinicalTrials.gov/show/NCT01251705
100407100407Phototherapeutic Keratectomy (PTK) on Recurrent Corneal ErosionsCompletedNo Results AvailableRecurrent Corneal ErosionsProcedure: Surgeryhttps://ClinicalTrials.gov/show/NCT01251692
100408100408Household Influenza Transmission StudyActive, not recruitingNo Results AvailableInfluenzaBehavioral: Hand washing|Device: Hand washing and surgical maskhttps://ClinicalTrials.gov/show/NCT01251679
100409100409Comparison of Hemoccult, Magstream and OC-Sensor Faecal Occult Blood Tests in Colorectal Cancer ScreeningCompletedNo Results AvailableColorectal CancerOther: Colonoscopyhttps://ClinicalTrials.gov/show/NCT01251666
100410100410A Phase I Dose Escalation Trial of Afatinib Plus Gemcitabine or Plus DocetaxelCompletedNo Results AvailableNeoplasmsDrug: Afatinib|Drug: Afatinib|Drug: docetaxel|Drug: gemcitabinehttps://ClinicalTrials.gov/show/NCT01251653

* Görseller ve İçerik tekif hakkına sahip olabilir